Platelet-Derived Growth Factor as an Antidepressant Treatment Selection Biomarker: Higher Levels Selectively Predict Better Outcomes with Bupropion-SSRI Combination

類似資料

• Interleukin 17 Selectively Predicts Better Outcomes with Bupropion-SSRI Combination: Novel T Cell Biomarker for Antidepressant Medication Selection
  著者:: Jha, Manish K., 等
  出版事項: (2017)
• Higher S100B Levels Predict Persistently Elevated Anhedonia with Escitalopram Monotherapy Versus Antidepressant Combinations: Findings from CO-MED Trial
  著者:: Jha, Manish K., 等
  出版事項: (2019)
• Can C-Reactive Protein Inform Antidepressant Medication Selection in Depressed Outpatients? Findings from the CO-MED Trial
  著者:: Jha, Manish K., 等
  出版事項: (2017)
• Proteomics profiling of inflammation-related biomarkers in antidepressant treatment response: Findings from the CO-MED trial
  著者:: Gadad, Bharathi S., 等
  出版事項: (2017)
• Peripheral Biomarkers of Major Depression and Antidepressant Treatment Response: Current Knowledge and Future Outlooks
  著者:: Gadad, Bharathi S, 等
  出版事項: (2017)